Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes

NCT02964572 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: Glimepiride
DRUG: Empagliflozin

Sponsor

Yonsei University